0001766721-19-000004.txt : 20190808 0001766721-19-000004.hdr.sgml : 20190808 20190808154007 ACCESSION NUMBER: 0001766721-19-000004 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190808 DATE AS OF CHANGE: 20190808 EFFECTIVENESS DATE: 20190808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aisling Capital Management LP CENTRAL INDEX KEY: 0001766721 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19070 FILM NUMBER: 191009281 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-651-6380 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001766721 XXXXXXXX 06-30-2019 06-30-2019 Aisling Capital Management LP

888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106

13F HOLDINGS REPORT 028-19070 N Robert J. Wenzel 212651-6374 /s/ Robert J. Wenzel New York NY 08-08-2019 0 14 232738 false INFORMATION TABLE 2 chart.xml Aclaris Theraputics Inc (ACRS) COM 00461U105 1389 634455 SH SOLE 634455 0 0 Aeglea Biotherapeutics Inc (AGLE) COM 00773J103 8844 1291151 SH SOLE 1291151 0 0 Arcus Biosciences, Inc. (RCUS) COM 03969F109 2650 333333 SH SOLE 333333 0 0 Atreca (BCEL) CL A COM 04965G109 7303 387653 SH SOLE 387653 0 0 AVROBIO, Inc. (AVRO) COM 05455M100 13203 811998 SH SOLE 811998 0 0 Biohaven Pharmaceutical Holding Company Ltd. (BHVN) COM G11196105 12021 274513 SH SOLE 274513 0 0 BridgeBio (BBIO) COM 10806X102 103449 3835722 SH SOLE 3835722 0 0 Eidos Therapeutics, Inc. (EIDIX) COM 28249H104 34922 1123630 SH SOLE 1123630 0 0 Marker Therapeutics, Inc. (MRKR) COM 57055L107 15840 2000000 SH SOLE 2000000 0 0 Nabriva Therapeutics plc (NBRV) SHS G63637105 4396 1809259 SH SOLE 1809259 0 0 ObsEva SA (OBSV) COM H5861P103 15679 1386338 SH SOLE 1386338 0 0 Sunesis Pharmaceuticals, Inc. (SNSS) COM 867328700 5548 7600000 SH SOLE 7600000 0 0 Verona Pharma plc (VRNA) COM 925050106 2262 443596 SH SOLE 443596 0 0 Zosano Pharma Corporation (ZSAN) COM 98979H202 5232 16000000 SH SOLE 16000000 0 0